Rating 4.8

2,400 reviews

Mounjaro® is Eli Lilly's brand of tirzepatide, and it is a prescription medication for type 2 diabetes. Getting it online is possible through a licensed telehealth practice, but the clinical requirements are exactly the same as they would be in a physical clinic: a licensed prescriber, a diagnosis that matches what the medication is approved to treat, and no contraindications.

Mounjaro is FDA approved as an addition to diet and exercise to improve blood sugar control in adults with type 2 diabetes. That is the indication. Mounjaro is not approved for chronic weight management, and it is not approved for type 1 diabetes. Indications are added to labels over time, so the prescribing information is the authority on the current list.

The list price is a reference figure, not what most people pay, and the gap between a covered copay and a cash price is the largest variable. Settle the coverage question before you fill rather than at the counter. Our insurance page covers what a prior authorization typically asks for and what to do if it is denied.

Society's pricing starts at $1,395 per month, above both manufacturer routes. What it adds is a personalized treatment plan, labs, expedited shipping and continuous clinical assistance rather than a box of medication alone. Self-pay prices here have been reset more than once since 2024, which is why the table points at LillyDirect rather than printing a figure that ages badly.

Society also offers personalized compounded tirzepatide, prescribed by a licensed US practitioner for a specific patient's needs, from $249 per month. Compounded medications are not FDA-approved and have not been evaluated by the Food and Drug Administration for safety, efficacy, or quality, and a compounded formulation is not the same product as Mounjaro and is not equivalent to it. Whether one is appropriate is a clinical decision, not a menu choice. Our compounded versus brand GLP-1 page sets out exactly how the rules governing this route have narrowed.

Same active ingredient, different approved use. Mounjaro and Zepbound are both tirzepatide, both made by Eli Lilly, and both available in the same six strengths from 2.5 mg to 15 mg once weekly. Mounjaro is approved for type 2 diabetes. Zepbound is approved for chronic weight management and for obstructive sleep apnea in adults with obesity.

They are separate prescription products. A pharmacy cannot substitute one for the other, your prescriber has to write for the specific product, and plans frequently cover one while excluding the other.

Society dispenses Mounjaro and does not dispense Zepbound. The fuller comparison, including dosing, trial data and cost, is on our Zepbound page. The molecule itself, across both brands, is covered on our tirzepatide page.

Mounjaro contains tirzepatide, which is an agonist at two gut hormone receptors rather than one: GIP and GLP-1. Most medications in this class act on GLP-1 alone.

In type 2 diabetes, the effects that matter are increased glucose-dependent insulin secretion, reduced glucagon, and slower gastric emptying. Because the insulin effect scales with blood glucose rather than driving it down indiscriminately, the hypoglycemia risk with Mounjaro alone is low. It rises when Mounjaro is combined with insulin or a sulfonylurea, and doses of those are often reduced when tirzepatide is started.

The same mechanisms reduce appetite, which is why weight change is commonly observed in people taking it. That observation is not an approved indication, and the product studied and approved for chronic weight management is Zepbound.

The available strengths are 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg. Take it on the same day each week, at any time of day, with or without food. The day can be changed as long as there are at least three days (72 hours) between doses. If you miss a dose, take it within four days (96 hours). If longer has passed, skip it and resume your normal schedule.

Mounjaro is injected subcutaneously, into the fat layer just under the skin. Three sites are used: the abdomen, staying at least two inches from your navel, the front of the thigh, and the back of the upper arm, which usually needs another person. Rotate the site each week, and avoid skin that is tender, bruised, red, hard or scarred.

With the single-dose pen. Check the label, strength and expiry, and check the solution is clear and colorless. Clean the site and let it dry. Unlock the pen, press the flat base firmly against your skin, then press and hold the injection button until you hear a second click and the grey plunger is visible, usually five to ten seconds. Dispose of the pen in an FDA-cleared sharps container without recapping it.

Storage. Keep Mounjaro refrigerated at 36°F to 46°F (2°C to 8°C) in the original carton. It can be kept at room temperature up to 86°F (30°C) for up to 21 days if needed. Do not freeze it, and do not use it if it has been frozen. Always follow the Instructions for Use supplied with your product, because the pen and the vial presentation have different instructions and device instructions change. Our general injection guide covers technique in more detail.

Boxed warning: risk of thyroid C-cell tumors. In rodent studies, tirzepatide caused thyroid C-cell tumors. It is not known whether it causes these tumors, including medullary thyroid carcinoma, in humans. Mounjaro must not be used by anyone with a personal or family history of medullary thyroid carcinoma (MTC), or by anyone with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Serious risks in the prescribing information include pancreatitis, gallbladder problems, low blood sugar (particularly with insulin or a sulfonylurea), serious allergic reactions, acute kidney injury from dehydration, diabetic retinopathy complications, and food remaining in the stomach during general anesthesia or deep sedation.

The most common side effects are nausea, diarrhea, decreased appetite, vomiting, constipation, indigestion and abdominal pain (Eli Lilly, Mounjaro prescribing information). They are usually worst in the first weeks and after each dose increase, then ease as tolerance develops. The four-week interval between increases exists for that reason.

Tell your prescriber before starting if you have had pancreatitis, have a history of gallbladder disease, have diabetic retinopathy, have kidney disease, have any severe gastrointestinal condition including gastroparesis, are taking insulin or a sulfonylurea, are pregnant or planning pregnancy, or are breastfeeding. Tirzepatide can also reduce the effectiveness of oral contraceptives, so if you use one, ask about a backup method during the first weeks and after each dose increase.

Tell any surgeon or anesthesiologist that you take tirzepatide well before a procedure. Slowed gastric emptying means food can remain in the stomach longer than expected under general anesthesia or deep sedation. This is a summary, not the full label. Read the complete prescribing information and medication guide, and our Mounjaro safety information.

Society is a telehealth practice. A licensed US practitioner reviews your history, determines whether a GLP-1 medication is appropriate for you and which one, and manages dosing and follow-up over time. It starts with a free 2-minute evaluation, and most members hear back from a provider within a day or two.

What a plan includes. A personalized treatment plan, the medication, labs, expedited shipping and continuous clinical assistance, with free discreet delivery in 1 to 2 days and no insurance required. More than 10,000 patients have been treated and support typically replies within 24 hours. You can pause, switch or cancel anytime, and the first two months of any treatment plan are strictly non-refundable, which is worth knowing before you start rather than after. Providers are licensed in the state where the patient is located at the time of consultation, so availability may vary by state.

Brand Mounjaro from $1,395 per month for its approved type 2 diabetes use, with the treatment plan, labs, expedited shipping and continuous clinical assistance included. A licensed US practitioner decides what fits your diagnosis before anything is prescribed.

* Individual results may vary, and not all patients will qualify for treatment. Always consult a licensed healthcare provider before starting or modifying any medical treatment.

Society facilitates access to consultations with independent, licensed healthcare providers who evaluate each patient and determine eligibility for treatment. Prescription products require an online medical evaluation. Medications are prescribed by independent physicians and dispensed by licensed U.S. pharmacies or a patient's preferred pharmacy. Only a qualified healthcare provider can determine whether a treatment is appropriate for an individual's specific medical needs.
Providers are licensed in the state where the patient is located at the time of consultation, and availability may vary by state.
Society's services are intended for individuals 18 years of age or older. Age verification may be required as part of the intake process.
‍Society partners with licensed U.S. pharmacies. Certain treatments may include compounded medications, which are not FDA-approved and have not been evaluated by the Food and Drug Administration for safety, efficacy, or quality. Compounded medications may be prescribed by a healthcare provider based on individual patient needs or during periods of drug shortages. FDA-approved GLP-1 medications—such as Ozempic® (semaglutide), Wegovy® (semaglutide), and Zepbound® (tirzepatide)—are not compounded. Society is not affiliated with, endorsed by, or sponsored by the manufacturers of these products. All trademarks and brand names belong to their respective owners.
GLP-1–based treatments may carry risks, including the potential for thyroid C-cell tumors. These medications should not be used by individuals with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Please consult a healthcare provider for complete prescribing and safety information.
Prescription medications are dispensed only when determined appropriate by a licensed healthcare provider following an online medical evaluation. No prescription is guaranteed, and treatment decisions are made solely at the prescriber's clinical discretion.
Statements on this website have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease. Images shown are for illustrative purposes only; actual product appearance may vary.